Previous close | 13.52 |
Open | 13.58 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1400 |
Day's range | 13.58 - 13.95 |
52-week range | 11.44 - 16.60 |
Volume | |
Avg. volume | 2,048,406 |
Market cap | 3.201B |
Beta (5Y monthly) | 1.28 |
PE ratio (TTM) | 72.95 |
EPS (TTM) | 0.19 |
Earnings date | 22 Feb 2023 |
Forward dividend & yield | 1.20 (8.89%) |
Ex-dividend date | 16 Nov 2022 |
1y target est | 14.08 |
IRVINE, Calif., February 02, 2023--Sabra Health Care REIT, Inc. ("Sabra", "the Company") (Nasdaq: SBRA) announced today that since September 30, 2022, the Company has received roughly $185 million of gross proceeds related to previously disclosed disposition activity. In addition, the 24 properties formerly leased to North American ("North American") have been successfully transitioned to Ensign ("Ensign") (Nasdaq: ENSG) and the Avamere Family of Companies ("Avamere").
IRVINE, Calif., February 01, 2023--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2022 fourth quarter earnings release on February 21, 2023, after the close of trading.
IRVINE, Calif., January 27, 2023--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2022 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: